{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for azelaic root_modifications_structuralModifications_molecularFragment_refPname in root_modifications_structuralModifications_molecularFragment_refPname (approximate match)
Status:
Investigational
Source:
INN:trovostobart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:etakafusp alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:Calpurbatug [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT04225039: Phase 2 Interventional Active, not recruiting Glioblastoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:adintrevimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:bempikibart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:delpacibart zotadirsen [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:becotatug vedotin [INN]
Source URL:
Class:
PROTEIN